Arrowstreet Capital
AFMD

Arrowstreet Capital’s Affimed AFMD Stock Holding History

Arrowstreet Capital’s Portfolio AFMD Stock Details AFMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-7,063
Closed -$390K – 1157
2021
Q4 		$390K Sell
7,063
-40,054
-85% -$2.47M ﹤0.01% 1310
2021
Q3 		$2.91M Buy
+47,117
New +$3.1M ﹤0.01% 1057
2021
Q2 		– Sell
-46,669
Closed -$3.69M – 1833
2021
Q1 		$3.69M Sell
46,669
-27,310
-37% -$1.77M ﹤0.01% 1311
2020
Q4 		$4.31M Buy
+73,979
New +$3.48M 0.01% 1252
2020
Q2 		– Sell
-2,874
Closed -$45K – 2273
2020
Q1 		$45K Sell
2,874
-15,345
-84% -$365K ﹤0.01% 1825
2019
Q4 		$499K Buy
18,219
+6,948
+62% +$186K ﹤0.01% 1487
2019
Q3 		$331K Buy
+11,271
New +$335K ﹤0.01% 1401

Other funds holding AFMD

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Arrowstreet Capital's AFMD Position: Q1 2022 in Review

Arrowstreet Capital sold out of Affimed (AFMD) in Q1 2022, closing a stake of 7,063 shares — an estimated $390K sold.

Arrowstreet Capital first reported a position in AFMD in Q3 2019 and held it in 7 quarters. The position peaked at $4.31M in Q4 2020. 118 funds tracked by Wall St. Rank hold AFMD as of Q1 2022.

  • Arrowstreet Capital reported no remaining Affimed position as of Q1 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 7,063 Affimed shares in Q1 2022, an estimated $390K.
  • Arrowstreet Capital first reported a position in Affimed in Q3 2019 and held it in 7 quarters.
  • Arrowstreet Capital's Affimed position peaked at $4.31M in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Affimed as of Q1 2022.

Based on Arrowstreet Capital's 13F filing for Q1 2022, filed 13 May 2022.